Literature DB >> 26985291

Beyond PAINs: Chemotype Sensitivity of Protein Methyltransferases in Screens.

Cen Gao1, Brandon J Margolis1, John M Strelow1, Lewis R Vidler2, Mary M Mader1.   

Abstract

Screening of the relatively new target class, the lysine and arginine methyltransferases (MTases), presents unique challenges in the identification and confirmation of active chemical matter. Examination of high throughput screening data generated using Scintillation Proximity Assay (SPA) format for a number of protein MTase targets reveals sensitivity to both the known pan assay interference compounds (PAINS) and also other scaffolds not currently precedented as assay interferers. We find that, in general, true actives show significant selectivity within the MTase family. With the exception of slight modifications of SAM-like compounds, scaffolds that are observed frequently in multiple MTase assays should be viewed with caution and should be carefully validated before following up.

Entities:  

Keywords:  HTS; Methyltransferase; PAINS; epigenetics; promiscuity

Year:  2015        PMID: 26985291      PMCID: PMC4753540          DOI: 10.1021/acsmedchemlett.5b00375

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  24 in total

1.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.

Authors:  Jonathan B Baell; Georgina A Holloway
Journal:  J Med Chem       Date:  2010-04-08       Impact factor: 7.446

2.  Discovery, design, and synthesis of indole-based EZH2 inhibitors.

Authors:  Victor S Gehling; Rishi G Vaswani; Christopher G Nasveschuk; Martin Duplessis; Priyadarshini Iyer; Srividya Balasubramanian; Feng Zhao; Andrew C Good; Robert Campbell; Christina Lee; Les A Dakin; Andrew S Cook; Alexandre Gagnon; Jean-Christophe Harmange; James E Audia; Richard T Cummings; Emmanuel Normant; Patrick Trojer; Brian K Albrecht
Journal:  Bioorg Med Chem Lett       Date:  2015-06-19       Impact factor: 2.823

3.  Potent inhibition of DOT1L as treatment of MLL-fusion leukemia.

Authors:  Scott R Daigle; Edward J Olhava; Carly A Therkelsen; Aravind Basavapathruni; Lei Jin; P Ann Boriack-Sjodin; Christina J Allain; Christine R Klaus; Alejandra Raimondi; Margaret Porter Scott; Nigel J Waters; Richard Chesworth; Mikel P Moyer; Robert A Copeland; Victoria M Richon; Roy M Pollock
Journal:  Blood       Date:  2013-06-25       Impact factor: 22.113

4.  Quantification of frequent-hitter behavior based on historical high-throughput screening data.

Authors:  J Willem M Nissink; Sam Blackburn
Journal:  Future Med Chem       Date:  2014-06       Impact factor: 3.808

5.  Chemistry: Chemical con artists foil drug discovery.

Authors:  Jonathan Baell; Michael A Walters
Journal:  Nature       Date:  2014-09-25       Impact factor: 49.962

6.  Discovery and Optimization of Tetramethylpiperidinyl Benzamides as Inhibitors of EZH2.

Authors:  Christopher G Nasveschuk; Alexandre Gagnon; Shivani Garapaty-Rao; Srividya Balasubramanian; Robert Campbell; Christina Lee; Feng Zhao; Louise Bergeron; Richard Cummings; Patrick Trojer; James E Audia; Brian K Albrecht; Jean-Christophe P Harmange
Journal:  ACS Med Chem Lett       Date:  2014-01-14       Impact factor: 4.345

7.  Structural and Kinetic Characterization of a Novel N-acetylated Aliphatic Amine Metabolite of the PRMT Inhibitor, EPZ011652.

Authors:  Nathalie Rioux; Lorna H Mitchell; Philip Tiller; Katie Plant; Joanne Shaw; Kerry Frost; Scott Ribich; Mikel P Moyer; Robert A Copeland; Richard Chesworth; Nigel J Waters
Journal:  Drug Metab Dispos       Date:  2015-04-17       Impact factor: 3.922

8.  Rules for identifying potentially reactive or promiscuous compounds.

Authors:  Robert F Bruns; Ian A Watson
Journal:  J Med Chem       Date:  2012-10-25       Impact factor: 7.446

9.  An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1.

Authors:  Kyle D Konze; Anqi Ma; Fengling Li; Dalia Barsyte-Lovejoy; Trevor Parton; Christopher J Macnevin; Feng Liu; Cen Gao; Xi-Ping Huang; Ekaterina Kuznetsova; Marie Rougie; Alice Jiang; Samantha G Pattenden; Jacqueline L Norris; Lindsey I James; Bryan L Roth; Peter J Brown; Stephen V Frye; Cheryl H Arrowsmith; Klaus M Hahn; Gang Greg Wang; Masoud Vedadi; Jian Jin
Journal:  ACS Chem Biol       Date:  2013-04-24       Impact factor: 5.100

10.  Identification of EZH2 and EZH1 small molecule inhibitors with selective impact on diffuse large B cell lymphoma cell growth.

Authors:  Shivani Garapaty-Rao; Christopher Nasveschuk; Alexandre Gagnon; Eric Y Chan; Peter Sandy; Jennifer Busby; Srividya Balasubramanian; Robert Campbell; Feng Zhao; Louise Bergeron; James E Audia; Brian K Albrecht; Jean-Christophe Harmange; Richard Cummings; Patrick Trojer
Journal:  Chem Biol       Date:  2013-10-31
View more
  1 in total

1.  Investigating the Behavior of Published PAINS Alerts Using a Pharmaceutical Company Data Set.

Authors:  Lewis R Vidler; Ian A Watson; Brandon J Margolis; David J Cummins; Michael Brunavs
Journal:  ACS Med Chem Lett       Date:  2018-07-10       Impact factor: 4.345

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.